ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 592,64
-0,52%
Dow Jones
40 211,72
0,53%
DAX
18 523,98
-0,41%
Brent Oil
83,625
-0,85%
Bitcoin
63 032,73
-2,80%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/10/202113h15Business WireTeva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
27/10/202113h15Business WireTeva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024NYSE:TEVATeva Pharmaceutical Industries Ltd
27/10/202113h14Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/10/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/10/202113h00Business WireTeva Reports Third Quarter 2021 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
26/10/202122h45Business WireTeva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug CandidateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/202114h00Business WireTeva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
13/10/202119h53Business WireNouvelles données relatives à l'innocuité du traitement par COPAXONE® (acétate de glatiramère) chez des mères allaitantes atteintes de sclérose en plaques cycliqueNYSE:TEVATeva Pharmaceutical Industries Ltd
13/10/202117h33Business WireNeue Sicherheitsdaten zur Behandlung mit COPAXONE® (Glatirameracetat) von stillenden Müttern mit schubförmiger multipler SkleroseNYSE:TEVATeva Pharmaceutical Industries Ltd
13/10/202108h00Business WireNew Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple SclerosisNYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/202119h59Business WireLes distances parcourues par les médicaments deviennent une source d'inquiétude pour les patients européensNYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/202116h54Business Wire„Medicine Miles“ werden zu einem Problem für europäische PatientenNYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/202113h21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/202108h00Business Wire‘Medicine Miles’ Becoming a Concern for European PatientsNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/202116h20Business WireTeva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/202114h00Business WireTeva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCNNYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/202113h30Business WireTeva Enlists Sarah Michelle Gellar to Launch “Inhaler Tales” Campaign to Raise Awareness About Inhaler Use in Asthma and COPDNYSE:TEVATeva Pharmaceutical Industries Ltd
28/09/202119h39Dow Jones NewsTeva Pharma Shares Up 6% After Louisiana Opioid SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
28/09/202118h40Business WireTeva Reaches Agreement with Louisiana to Settle the State’s Opioid-Related ClaimsNYSE:TEVATeva Pharmaceutical Industries Ltd
08/09/202114h00Business WireLate-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 2021 Showed AJOVY® (fremanezumab-vfrm) Injection Reduced More Monthly Migraine Days in a Network Meta-Analysis Study with Atogepant and RimegepantNYSE:TEVATeva Pharmaceutical Industries Ltd
31/08/202123h11Dow Jones NewsTeva, MedinCell Say FDA Accepts NDA for Schizophrenia TreatmentNYSE:TEVATeva Pharmaceutical Industries Ltd
31/08/202122h15Business WireTeva et MedinCell annoncent l’acceptation par la FDA du dossier de demande d’approbation du traitement TV46000/mdc-IRM pour les patients atteints de schizophrénieNYSE:TEVATeva Pharmaceutical Industries Ltd
31/08/202122h15Business WireTeva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with SchizophreniaNYSE:TEVATeva Pharmaceutical Industries Ltd
30/08/202114h00Business WireShowcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/08/202114h00Business WireTeva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive DyskinesiaNYSE:TEVATeva Pharmaceutical Industries Ltd
12/08/202122h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/202113h30Business WireTeva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent AnalysisNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/202113h00Business WireTeva Reports Second Quarter 2021 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/202114h00Business WireTeva Announces Changes to Executive Management TeamNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/202118h14Business WireTeva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
GEHC
GE HealthCare Technologies
NASDAQ
AGNC
AGNC Investment
BOV
CSNA3
SID NACIONAL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés